Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|October 3, 2003
[Recurrence of glomerulonephritis in transplanted kidney]G M Frascà, S Stefoni
Haemostasis|January 1, 1986
Use of defibrotide in renal transplantation in manV Bonomini, A Vangelista, S Stefoni, et al.
Clinical Nephrology|January 1, 1986
Parameters for indication of plasmapheresis and the interpretation of resultsA Vangelista, G M Frascà, V Bonomini
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
Glomerulonephritis in renal transplantationA Vangelista, G M Frascà, D Martella, et al.
Life Support Systems : the Journal of the European Society for Artificial Organs|July 1, 1986
Prevention of vascular graft lesions in renal transplant recipients with a new antithrombotic agent (defibrotide): a controlled studyG M Frascà, A Vangelista, C Raimondi, et al.
Kidney International|August 1, 1982
Immunological tubulo-interstitial deposits in IgA nephropathyG M Frascà, A Vangelista, G Biagini, et al.
The International Journal of Artificial Organs|January 1, 1991
Ten years experience with plasma exchange in renal transplantationG M Frascà, D Martella, A Vangelista, et al.
The International Journal of Artificial Organs|July 1, 1988
Optimization of heparin anticoagulation during membrane plasma separationG M Frascà, A Buscaroli, L C Borgnino, et al.
Journal of Clinical Apheresis|January 1, 1986
Effect of plasmapheresis on E-rosette receptors in SLE patientsA Vangelista, G M Frascà, A Nanni-Costa, et al.
The International Journal of Artificial Organs|July 1, 1990
Prevention of chronic glomerular uremia in steroid resistant glomerulonephritis. A clinical trial with a new antithrombotic agentG M Frascà, A Vangelista, D Martella, et al.
Pageof 15